- Harvard Bioscience, Inc. to Participate in the Benchmark Healthcare House Call Virtual Conference
- Harvard Bioscience Announces First Quarter 2024 Financial Results
- Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Call for May 7, 2024 at 8:00 AM ET
- Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth
- Harvard Bioscience, Inc. to Participate in March 2024 Investor Conferences: Sidoti’s Small Cap Conference and KeyBanc’s Life Sciences & MedTech Conference
- Harvard Bioscience Announces Fourth Quarter 2023 Financial Results
- Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting
- Harvard Bioscience Schedules Fourth Quarter 2023 Earnings Conference Call for March 7, 2024 at 8:00 AM ET
- Harvard Bioscience to Present at Benchmark Company’s Discovery One-On-One Investor Conference on December 7, 2023
- Harvard Bioscience to Present at Southwest IDEAS Investor Conference on November 16, 2023
More ▼
Key statistics
On Friday, Harvard Bioscience Inc (HBIO:NMQ) closed at 3.37, 1.20% above its 52-week low of 3.33, set on May 13, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.46 |
---|---|
High | 3.46 |
Low | 3.35 |
Bid | 3.30 |
Offer | 3.60 |
Previous close | 3.44 |
Average volume | 92.02k |
---|---|
Shares outstanding | 43.43m |
Free float | 40.27m |
P/E (TTM) | -- |
Market cap | 149.40m USD |
EPS (TTM) | -0.2029 USD |
Data delayed at least 15 minutes, as of May 17 2024 21:15 BST.
More ▼